The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.